← All Startups
D3 Bio Series B
Oncology and immunology medicine
D3 Bio is a biotechnology company focusing on the development and registration of medicines.
Location
China
Stage
Series B
Website
d3bio.com
LinkedIn
View profile
BiotechnologyLife SciencePharmaceutical
Founders
J
John Jin, PhD ’97
LinkedIn
News & Funding
2025-12-09 Series B Read article
Similar Startups
Centivax
Broad-spectrum vaccine
Stephanie Wisner ’16, ,
Celularity
Biotech cellular medicines
Robert Hariri, MD PhD ’87, ,
Ceribell Series C
Point-of-care EEG for seizure triage and treatment optimization
Xingjuan Chao, PhD ’05, ,
Freenome
Blood test to detect colorectal cancer
Gabriel Otte ’11, ,
Human Longevity Series B
Early detection for longer life
Robert Hariri, MD PhD ’87, ,
Moderna
mRNA vaccines
Robert Langer ’70, ,